Enliven Therapeutics (ELVN) Soars to 5-Year High as Analysts ‘Upbeat’.
Share this article
Corporate
Score 65
Bullish
Enliven Therapeutics (ELVN) Soars to 5-Year High as Analysts ‘Upbeat’
Mar 26, 2026 00:46 UTC
ELVN
Short term
Related Articles
Score 35
American Airlines Weighs Bringing Back Seatback Screens in Narrow-Body Fleet Revamp
Mar 27, 12:53
Score 85
Bullish
SoftBank Secures Record $40 Billion Bridge Loan for OpenAI Stake
Mar 27, 11:48
Score 85
Bullish
Novartis Acquires Excellergy for $2 Billion in Latest Biotech M&A Push
Mar 27, 11:43
Score 85
Bearish
Microsoft Set for Worst Quarter Since 2008 as AI Takes Two Bites
Mar 27, 10:35
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.